Humacyte, Inc. (NASDAQ:HUMA) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to the Humacyte Fourth Quarter Results Conference Call. Currently all participants are in listen-only mode.
Humacyte Inc. (HUMA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Eversept Partners Kamran Moghtaderi | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | ||
| 3. | Altium Capital Jacob Gottlieb | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | Tudor Investment Corp Paul Tudor Jones | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.54 | 6,493 | Officer | 22,018 | 2025-04-14 | Filing | |
| $1.53 | 20,000 | Officer | 40,600 | 2025-04-10 | Filing | |
| $1.55 | 7,500 | Officer | 7,500 | 2025-04-10 | Filing | |
| $1.32 | 50,000 | Director | 91,207 | 2025-04-08 | Filing | |
| $1.29 | 6,000 | Director | 8,400 | 2025-04-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.40 | 261,369 | Officer, Director | 1,730,884 | 2024-11-20 | Filing | |
| $4.34 | 427,459 | Officer, Director | 1,992,253 | 2024-11-19 | Filing | |
| $4.44 | 811,172 | Officer, Director | 2,419,712 | 2024-11-18 | Filing | |
| $4.40 | 261,369 | Director | 1,730,884 | 2024-11-20 | Filing | |
| $4.34 | 427,459 | Director | 1,992,253 | 2024-11-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Humacyte, Inc. (NASDAQ:HUMA) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte Third Quarter 2024 Results Conference Call. Currently, all participants are in a listen-only mode.
Humacyte, Inc. (NASDAQ:HUMA) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Humacyte's Second Quarter Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
Humacyte, Inc. (NASDAQ:HUMA) Q1 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte First Quarter 2024 Results Conference Call. Currently all participants are in a listen-only mode.
10 Stocks American Politicians are Buying in 2024
In this article, we will take a detailed look at the 10 Stocks American Politicians are Buying in 2024. For a quick overview of such stocks, read our article 5 Stocks American Politicians are Buying...
Humacyte, Inc. (NASDAQ:HUMA) Q4 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte 2023 Fourth Quarter Year-End Results Conference Call. Currently, all participants are in a listen-only mode.
11 Little-Known Penny Stocks With Massive Upside Potential
In this article, we will take a detailed look at the 11 Little-Known Penny Stocks With Massive Upside Potential. For a quick overview of such stocks, read our article 5 Little-Known Penny Stocks With...
Humacyte, Inc. (NASDAQ:HUMA) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Humacyte Third Quarter Results Conference Call. Currently, all participants are in a listen-only mode.
Humacyte, Inc. (NASDAQ:HUMA) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte Second Quarter Results Conference Call. Currently, all participants are in a listen-only mode.
Humacyte, Inc. (NASDAQ:HUMA) Q1 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte First Quarter Results Conference Call. Currently, all participants are in a listen-only mode.
Billionaire Hedge Funds
